QUANTUM Data Analytics has formed a JV with AI-42 Market Intelligence
QUANTUM Advisory & Data Analytics International GmbH (QUANTUM) has entered into a joint venture with AI-42 Market Intelligence Ltd.
QUANTUM, via the Quantum Terminal, explores each technological element of a company’s IP to form an individual knowledge profile. Combined with fundamental data, it draws a precise picture and gains completely new insights into more than 700,000 companies worldwide. The company’s corporate IP analytics dataset is rigorously matched with public and private companies worldwide and covers practically all patent data generated since electronic recording began. Indicators from top universities (Harvard, University of California, University of Hong Kong) and renowned institutions (OECD, NBER) have been implemented to provide unparalleled IP analytics.
AI-42 Market Intelligence is a UK-based leading artificial intelligence market provider.
Oaklins’ team in Austria structured the joint venture QUANTUM Advisory & Data Analytics International GmbH as a subsidiary of Oaklins Austria and AI-42 Market Intelligence Ltd.
Talk to the deal team
Related deals
BodhiCedric has acquired Network Media from Jellysmack
The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.
Learn moreCustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more